Aurdan Capital Management LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 10.7% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 17,270 shares of the healthcare conglomerate's stock after selling 2,063 shares during the period. UnitedHealth Group accounts for approximately 3.4% of Aurdan Capital Management LLC's portfolio, making the stock its 8th biggest position. Aurdan Capital Management LLC's holdings in UnitedHealth Group were worth $9,045,000 at the end of the most recent reporting period.
Several other institutional investors have also modified their holdings of the stock. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth about $26,000. Hurley Capital LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter worth about $28,000. Aster Capital Management DIFC Ltd acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $30,000. Kapitalo Investimentos Ltda acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $41,000. Finally, Copia Wealth Management acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $42,000. Hedge funds and other institutional investors own 87.86% of the company's stock.
Insider Activity
In other UnitedHealth Group news, Director Kristen Gil acquired 3,700 shares of the company's stock in a transaction on Thursday, May 15th. The shares were bought at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the acquisition, the director directly owned 3,818 shares of the company's stock, valued at $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer owned 10,398 shares in the company, valued at $3,171,390. This represents a 5.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders acquired a total of 109,408 shares of company stock worth $31,607,768 in the last ninety days. 0.28% of the stock is currently owned by company insiders.
UnitedHealth Group Trading Up 0.6%
Shares of NYSE UNH traded up $1.91 during midday trading on Friday, hitting $301.42. The stock had a trading volume of 5,787,602 shares, compared to its average volume of 7,655,490. The company has a market capitalization of $273.43 billion, a price-to-earnings ratio of 12.61, a PEG ratio of 1.45 and a beta of 0.45. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. The company has a fifty day moving average price of $316.42 and a 200 day moving average price of $442.28.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same period in the prior year, the firm earned $6.91 earnings per share. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a dividend of $2.21 per share. The ex-dividend date was Monday, June 16th. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a yield of 2.93%. UnitedHealth Group's payout ratio is 37.02%.
Analyst Ratings Changes
UNH has been the subject of a number of research analyst reports. JPMorgan Chase & Co. upped their price target on UnitedHealth Group from $405.00 to $418.00 and gave the company an "overweight" rating in a report on Friday, June 20th. Baird R W cut UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, June 11th. Truist Financial reiterated a "buy" rating and issued a $360.00 price objective (down previously from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Barclays cut their price objective on UnitedHealth Group from $350.00 to $337.00 and set an "overweight" rating for the company in a research report on Wednesday. Finally, Piper Sandler dropped their price target on UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating for the company in a research report on Tuesday, June 3rd. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $415.00.
Check Out Our Latest Research Report on UNH
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.